Skip to main content
Clinical Trials/CTRI/2022/06/043075
CTRI/2022/06/043075
Recruiting
未知

Evaluation of Continuous Non-Invasive BloodPressure Monitoring through Dozee

Turtle Shell Technologies0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: X- New Technology
Sponsor
Turtle Shell Technologies
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational

Investigators

Sponsor
Turtle Shell Technologies

Eligibility Criteria

Inclusion Criteria

  • 1\.Weight between 40 kgs to 150 kgs
  • 2\. Have been connected to ICU monitor for blood pressure measurements using both IBP and CBP
  • 3\. They/ legal representative are able and willing to provide written informed consent

Exclusion Criteria

  • Weight below 40kgs and above 150kgs
  • 2\. Currently pregnant
  • 3\. Have any condition that could interfere with the subjects ability to tolerate continuous monitoring with IBP or periodic monitoring with CBP
  • 4\. Exhibit injuries, deformities, intravenous lines, or other abnormalities that, in the opinion of the investigator, may prevent proper cuff application or functioning
  • 5\. Level of agitation or non\-compliance too high to enroll in opinion of PI
  • 6\. Needs the use of equipments whose operation can interfere with Dozeeâ??s signal
  • 7\. A significant medical condition in the judgment of the investigator, which
  • may compromise the study testing procedures

Outcomes

Primary Outcomes

Not specified

Similar Trials